4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-067954
SVP, Chief Business Officer sold 499 shares at $6.69 ($3,338)
From the SEC's structured data for this filing
Trades in this filing
Mitchener Stephen · SVP, Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-02 | Sale : show line 1 in the form | −499 | $6.69 | $3,338 | 3,296 | D |
| Open-market sales · 499 sh · avg $6.69 · $3,338 | ||||||
Loading xslF345X03/doc4.xml…